fTwo novel biomarkers, mesothelin and HE4, for diagnosis of ovarian carcinoma.
about
Mesothelin promotes cell proliferation in the remodeling of neonatal rat pancreas.Inhibition of mesothelin as a novel strategy for targeting cancer cells.Validation of LRG1 as a potential biomarker for detection of epithelial ovarian cancer by a blinded studyDetection of the HE4 protein in urine as a biomarker for ovarian neoplasms: Clinical correlates.Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125Elafin selectively regulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosisSerum folate receptor alpha, mesothelin and megakaryocyte potentiating factor in ovarian cancer: association to disease stage and grade and comparison to CA125 and HE4.Identification of high-risk patients by human epididymis protein 4 levels during follow-up of ovarian cancer.Gene expression analyses support fallopian tube epithelium as the cell of origin of epithelial ovarian cancer.Anti-HE4 antibodies in infertile women and women with ovarian cancer.Can ROMA algorithm stratify ovarian tumor patients better when being based on specific age ranges instead of the premenopausal and postmenopausal status?Diagnostic accuracy of urine HE4 in patients with ovarian cancer: a meta-analysis.Evaluation of serum mesothelin in malignant and benign ovarian masses.Serum concentrations of HE4 change little during in vitro fertilization.The Establishment of an HE4-CLIA Method and the Combined Analysis of HE4 and CA125 in Ovarian Cancer.Does the Risk of Ovarian Malignancy Algorithm Provide Better Diagnostic Performance Than HE4 and CA125 in the Presurgical Differentiation of Adnexal Tumors in Polish Women?
P2860
Q33735285-C3031E98-C655-4249-B47A-319D96CB2EA1Q34224746-CB55803B-4856-4930-A0BF-8BCD51ECA433Q35208879-8724763F-EAF1-419E-B7E5-53FF67DFB888Q35661217-A12AFDE9-DB7D-49AA-A6CC-C2D7A68D9E25Q35830931-CBFF0C44-F5B9-4A9B-9065-E23F0F63BC32Q35981299-921F1D97-884A-429D-AD2E-006E3BDBA986Q36808757-985B96A1-9D83-4E65-BCBA-DE4B04EF77A9Q36954678-B0BAF177-8BDF-4E11-99BC-DF01EAE3E097Q37091852-2C6B1A64-EB36-491A-910B-FBC8DD7074EDQ37107033-704E7707-BF86-4BF7-BD5A-0F66CA79D3DEQ37188163-BEF34D32-DC63-408F-9D4E-9EC5A6DA5869Q37706040-EDCDDFFB-EE5E-4CDF-8685-296CB66D4E79Q46245510-DD1DE789-8BC2-4F69-99F7-EEC3B21CEDBBQ50698085-CAF475D9-B74C-4C8C-8564-F29C1DACE2A6Q51435881-D33A1F5E-A79E-4563-AC4E-67D0884A460FQ55280402-610A4802-C2C8-4054-BA1A-D7E374D30B1C
P2860
fTwo novel biomarkers, mesothelin and HE4, for diagnosis of ovarian carcinoma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
fTwo novel biomarkers, mesothelin and HE4, for diagnosis of ovarian carcinoma.
@ast
fTwo novel biomarkers, mesothelin and HE4, for diagnosis of ovarian carcinoma.
@en
type
label
fTwo novel biomarkers, mesothelin and HE4, for diagnosis of ovarian carcinoma.
@ast
fTwo novel biomarkers, mesothelin and HE4, for diagnosis of ovarian carcinoma.
@en
prefLabel
fTwo novel biomarkers, mesothelin and HE4, for diagnosis of ovarian carcinoma.
@ast
fTwo novel biomarkers, mesothelin and HE4, for diagnosis of ovarian carcinoma.
@en
P2860
P1476
fTwo novel biomarkers, mesothelin and HE4, for diagnosis of ovarian carcinoma.
@en
P2093
Ingegerd Hellstrom
Karl Erik Hellstrom
P2860
P304
P356
10.1517/17530059.2011.559459
P407
P577
2011-05-01T00:00:00Z